Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Next Generation Sequencing (NGS) Application for HLA Typing of Donors and Recipients of Hematopoietic Stem Cells

NCT02892292 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT02892292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02892292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Next Generation Sequencing (NGS) Application for HLA Typing of Donors and Recipients of Hematopoietic Stem Cells
Lead sponsor
University Hospital, Brest
Phase
Observational
Overall status
Completed
Start date
July 31, 2014
Completion date
May 31, 2015
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

next generation sequencing for hla typing